Press Release: ParaZero Reports 2025 Financial Results

Dow Jones
Mar 26

KFAR SABA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced its financial results for year ended December 31, 2025.

Key Highlights of ParaZero's Achievements in 2025 & Recent Highlights:

   -- Sales increased by 12.3% to $1,046,644 for the year ended December 31, 
      2025, primarily driven by newly developed products in the defense sector 
 
   -- Three purchase orders received from Israeli defense entities for 
      DefendAir Counter-Unmanned Aerial Systems solutions reinforcing trust and 
      operational reliance on ParaZero's DefendAir platform. 
 
   -- Cash position strengthened with registered direct offerings in 2026 
      yielding approximately $7.5 million in gross proceeds. 

Commercial and Regulatory Milestones

   -- In January 2025, ParaZero announced that it received official approval 
      from the Israeli Defense Export Controls Agency $(DECA)$ under the Israel 
      Ministry of Defense for the marketing of the DefendAir counter-UAS 
      (C-UAS) solution. 
 
   --  In April 2025, ParaZero received a marketing approval from DECA for the 
      DropAir$(TM)$ Precision Airdrop System, developed in collaboration with 
      Heven Drones, a leading U.S. drone manufacturer with roots in Israel that 
      specializes in custom autonomous UAS platforms. 
 
   -- In October 2025, ParaZero announced the signing of a significant purchase 
      order with Airobotics Ltd.(an Ondas company), a premier provider of 
      robotic automation solutions, for the delivery of the company's advanced 
      safety systems. 
 
   -- In November 2025, ParaZero received a significant purchase order for its 
      DefendAir anti-drone defense systems from a Dutch distributor, one of 
      Europe's largest integrators that serves as a leading supplier of defense 
      and homeland security applications. 
 
   -- In December 2025, ParaZero signed a distribution agreement with a leading 
      Western European distributor specializing in advanced defense systems and 
      force training solutions, which grants the distributor exclusive rights 
      to distribute the DefendAir C-UAS across multiple Western European 
      countries. 
 
   -- In January 2026, ParaZero announced the receipt of the first purchase 
      order from a main Israeli defense entity for the DefendAir solution. 
 
   -- In February 2026, ParaZero announced the receipt of an additional order 
      from a second branch at an Israeli defense entity for the DefendAir 
      solution. The order included: 
 
          -- Specialized Launchers: High-precision net-launchers designed for 
             rapid deployment in urban and field environments, enabling 
             soft-kill interception of hostile drones with minimal collateral 
             damage. 
 
          -- Interception Pods: net-pods compatible with handheld, stationary, 
             and drone-mounted configurations, providing layered defense for 
             troops, convoys, and critical infrastructure. 
 
          -- Training Package: A comprehensive suite of simulation-based and 
             live-fire training modules to ensure operational readiness, 
             including system integration, maintenance, and tactical deployment 
             scenarios. 
 
   -- In March 2026, ParaZero announced the receipt of a new purchase order 
      from an Israeli defense entity for the DefendAir solution. The order 
      included the delivery of an evaluation kit including DefendAir's net pods 
      live exercise and training to support rapid operational deployment and 
      maximize readiness. 
 
   -- In March 2026, ParaZero signed a strategic cooperation agreement with 
      BonV Aero, a leading Indian aerospace and defense technologies 
      manufacturer, under which BonV Aero will market the DefendAir C-UAS 
      solutions in India, following a successful live demonstration to a key 
      Indian security entity. 

Full Year 2025 Financial Highlights:

   -- Sales increased by 12.3%, to $1,046,664 for the year ended December 31, 
      2025, compared to $932,154 for the year ended December 31, 2024. This 
      increase was mainly attributed to the company shifting towards sales of 
      newly developed products, mainly in the defense sector, and original 
      equipment manufacturer integrations that contributed to a higher volume 
      of sales. 
 
   -- Cost of sales increased by 14.1%, to $996,701 for the year ended 
      December 31, 2025, compared to $873,861 for the year ended December 31, 
      2024. The increase was mainly due to the increase of an inventory 
      write-off of $194,344 during the year ended December 31, 2025. 
 
   -- Research and development expenses increased by 9.1%, to $2,338,221 for 
      the year ended December 31, 2025, compared to $2,143,353 for the year 
      ended December 31, 2024. The increase resulted mainly from labor costs 
      due to the increased number of employees and consultants' costs. 
 
   -- Sales and marketing expenses increased by 49.7%, to $1,618,187 for the 
      year ended December 31, 2025, compared to $1,081,003 for the year ended 
      December 31, 2024. The increase resulted mainly from labor costs, 
      marketing and promotion services and travel and conferences participation 
      costs. 
 
   -- General and administrative expenses increased by 51.7%, to $3,640,967 for 
      the year ended December 31, 2025, compared to $2,400,000 for the year 
      ended December 31, 2024. The increase resulted mainly from non-cash 
      expenses of $1,086,247 related to grants pursuant to our equity incentive 
      plan. 
 
   -- Net loss and comprehensive loss decreased by 51%, to $5,412,163 for the 
      year ended December 31, 2025, compared to a net loss of $11,054,230 for 
      the year ended December 31, 2024. The decrease was the result of changes 
      in fair value of derivative warrant liabilities, set off by an increase 
      in expenses related to grants pursuant to our equity incentive plan along 
      with an increase of operating expenses, as described above. 
 
   -- The loss per share for the year ended December 31, 2025, was $0.31 
      compared to loss per share of $0.99 for the year ended December 31, 2024. 
 
   -- As of December 31, 2025, the company's cash, cash equivalents, and 
      short-term deposits was approximately $4.2 million. 

A copy of ParaZero's annual report on Form 20-F for the year ended December 31, 2025 has been filed with the U.S. Securities and Exchange Commission at https://www.sec.gov/ and posted on ParaZero's investor relations website at https://parazero.com/investor-relations/. ParaZero will deliver a hard copy of its annual report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request at michal@efraty.com.

About ParaZero Technologies

ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a recognized leader in advanced drone technologies, supporting commercial, industrial, and governmental operations worldwide. The company's product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments; and DropAir, a precision aerial delivery system. ParaZero's mission is to redefine the boundaries of aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security. For more information, visit https://parazero.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ("SEC"), including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the SEC on March 26, 2026 and in subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not

incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.

Investor Relations Contact:

Michal Efraty

Investor Relations

michal@efraty.com

 
 
                      PARAZERO TECHNOLOGIES LTD. 
                             BALANCE SHEETS 
                              (US dollars) 
 
                                           December 31,  December 31, 
                                     Note      2025          2024 
ASSETS 
CURRENT ASSETS: 
Cash and cash equivalents                     2,159,313     4,178,866 
Short term deposits                           2,000,000            -- 
Trade receivables                               185,494       114,564 
Other current assets                    3       283,010       421,919 
Inventories                             5       204,480       394,193 
                                           ------------  ------------ 
TOTAL CURRENT ASSETS                          4,832,297     5,109,542 
                                           ------------  ------------ 
 
NON-CURRENT ASSETS: 
Restricted deposit                     2Z        80,721        68,001 
Prepaid expenses                                 12,153        33,333 
Operating lease right-of-use asset      6       273,925       418,790 
Property and equipment, net             7       106,224       107,906 
                                           ------------  ------------ 
TOTAL NON-CURRENT ASSETS                        473,023       628,030 
                                           ------------  ------------ 
 
TOTAL ASSETS                                  5,305,320     5,737,572 
                                           ------------  ------------ 
 
 
 
                       PARAZERO TECHNOLOGIES LTD. 
                             BALANCE SHEETS 
                              (US dollars) 
 
                                          December 31,   December 31, 
                                    Note      2025           2024 
LIABILITIES AND SHAREHOLDERS' 
EQUITY (DEFICIT) 
CURRENT LIABILITIES: 
Trade payables                                 116,491        184,247 
Operating lease liabilities            6       245,682        202,563 
Other current liabilities              9       966,612        933,995 
                                          ------------   ------------ 
TOTAL CURRENT LIABILITIES                    1,328,785      1,320,805 
                                          ------------   ------------ 
 
NON-CURRENT LIABILITIES: 
Derivative warrant liabilities       13A       758,872      4,511,491 
Operating lease liabilities, net 
 of current portion                             61,002        216,917 
                                          ------------   ------------ 
TOTAL NON-CURRENT LIABILITIES                  819,874      4,728,408 
                                          ------------   ------------ 
 
SHAREHOLDERS' EQUITY (DEFICIT): 
Ordinary shares, NIS 0.02 par 
 value: Authorized 200,000,000 as 
 of December 31, 2025 and December 
 31, 2024; Issued and outstanding 
 19,666,030 and 12,817,092 shares 
 as of December 31, 2025 and as of 
 December 31, 2024, respectively      10       111,163         72,061 
Additional paid-in capital                  37,934,948     29,093,585 
Accumulated losses                         (34,889,450)   (29,477,287) 
                                          ------------   ------------ 
TOTAL SHAREHOLDERS' EQUITY 
 (DEFICIT)                                   3,156,661       (311,641) 
                                          ------------   ------------ 
 
TOTAL LIABILITIES AND 
 SHAREHOLDERS' EQUITY (DEFICIT)              5,305,320      5,737,572 
                                          ------------   ------------ 
 
 
 
                    PARAZERO TECHNOLOGIES LTD. 
                 STATEMENTS OF COMPREHENSIVE LOSS 
                           (US dollars) 
 
                                  Year ended December 31, 
                            ----------------------------------- 
                      Note     2025         2024        2023 
                            ----------   ----------   --------- 
Sales                   11   1,046,664      932,154     620,508 
Cost of Sales                  996,701      873,861     476,610 
                            ----------   ----------   --------- 
Gross profit                    49,963       58,293     143,898 
Research and 
 development 
 expenses                    2,338,221    2,143,353     636,801 
Selling and 
 marketing expenses          1,618,187    1,081,003     487,904 
General and 
 administrative 
 expenses                    3,640,967    2,400,000   1,472,872 
Initial public 
 offering expenses      2I          --           --     345,925 
                            ----------   ----------   --------- 
Operating loss               7,547,412    5,566,063   2,799,604 
Change in fair value 
 of convertible 
 notes                   8          --           --     504,976 
Change in fair value 
 of derivative 
 warrant 
 liabilities           13A  (1,918,203)   5,688,891     277,600 
Issuance expenses 
 attributable to 
 derivate warrant 
 liability             10B          --           --     247,129 
Interest expenses on 
 related party loan     15          --           --     152,745 
Other finance 
 income, net                  (217,046)    (200,724)   (210,675) 
                            ----------   ----------   --------- 
 
Net loss and 
 comprehensive loss          5,412,163   11,054,230   3,771,379 
                            ----------   ----------   --------- 
 
Net loss per 
 ordinary share, 
 basic and diluted                0.31         0.99        0.77 
                            ----------   ----------   --------- 
Weighted-average 
 number of ordinary 
 shares outstanding, 
 basic and diluted 
 (*)                        17,473,499   11,129,978   4,891,071 
                            ----------   ----------   --------- 
 
 
 
PARAZERO TECHNOLOGIES LTD. 
 STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) 
 (US dollars) 
 
                  Ordinary shares    Additional 
                Number of             paid-in     Accumulated 
                  shares    Amount     Capital       Losses        Total 
                ----------  ------- 
                                        U.S. dollars 
BALANCE AS OF 
 DECEMBER 31, 
 2022            3,597,442   21,456  12,988,292   (14,651,678)   (1,641,930) 
Stock based 
 compensation           --       --     490,015            --       490,015 
Conversion of 
 convertible 
 note into 
 ordinary 
 shares            504,976    2,734   2,017,170            --     2,019,904 
Issuance of 
 ordinary 
 shares and 
 warrants upon 
 initial 
 public 
 offering, net 
 of issuance 
 costs           1,950,000   10,561   5,919,064            --     5,929,625 
Issuance of 
 ordinary 
 shares, 
 pre-funded 
 warrants, and 
 warrants upon 
 private 
 placement, 
 net of 
 issuance 
 costs (*)       4,021,538   21,476   3,045,180            --     3,066,656 
Benefit to the 
 Company by an 
 equity holder 
 with respect 
 to funding 
 transactions           --       --      12,167            --        12,167 
Comprehensive 
 loss                   --       --          --    (3,771,379)   (3,771,379) 
BALANCE AS OF 
 DECEMBER 31, 
 2023           10,073,956   56,227  24,471,888   (18,423,057)    6,105,058 
Stock based 
 compensation           --       --      75,357            --        75,357 
Exercise of 
 pre-funded 
 warrants and 
 consultants 
 warrants (*)    1,088,590    5,792      (5,792)           --            -- 
Exercise of 
 warrants A      1,654,546   10,042   4,552,132            --     4,562,174 
Comprehensive 
 loss                                             (11,054,230)  (11,054,230) 
BALANCE AS OF 
 DECEMBER 31, 
 2024           12,817,092   72,061  29,093,585   (29,477,287)     (311,641) 
Issuance of 
 ordinary 
 shares and 
 pre-funded 
 warrants, net 
 of issuance 
 costs - 
 February 2025 
 (Note 10f)      2,818,182   15,762   2,516,733                   2,532,495 
Issuance of 
 ordinary 
 shares and 
 pre-funded 
 warrants, net 
 of issuance 
 costs - 
 August 2025 
 (Note 10g)      2,000,001   11,748   2,009,749                   2,021,497 
Stock based 
 compensation                         1,233,263                   1,233,263 
Issuance of 
 shares upon 
 restricted 
 share units 
 vesting           886,398    5,244      (5,244)                         -- 
Exercise of 
 series A 
 warrants 
 (Note 10)       1,144,357    6,348   3,086,862                   3,093,210 
Comprehensive 
 loss                                              (5,412,163)   (5,412,163) 
BALANCE AS OF 
 DECEMBER 31, 
 2025           19,666,030  111,163  37,934,948   (34,889,450)    3,156,661 
 
(*) Includes shares issued following a cashless exercise 
 
 
 
                      PARAZERO TECHNOLOGIES LTD. 
                       STATEMENTS OF CASH FLOWS 
                             (US dollars) 
 
                                     Year ended December 31, 
                              ------------------------------------- 
                                 2025         2024          2023 
                              ----------   -----------   ---------- 
CASH FLOWS FROM OPERATING 
ACTIVITIES: 
Net loss                      (5,412,163)  (11,054,230)  (3,771,379) 
Adjustments required to 
reconcile net loss to net 
cash used in operating 
activities: 
Depreciation                      29,174        22,814       17,087 
Loss on disposal of property 
 and equipment                       312 
Stock based compensation       1,233,263        75,357       14,815 
Interest expenses with 
 respect to funding from 
 related party                        --            --      112,373 
Change in fair value of 
 convertible loan                     --            --      504,976 
Changes in fair value of 
 derivative liabilities       (1,918,203)    5,688,891      277,600 
Issuance expenses 
 attributable to derivative 
 warrant liabilities                  --            --      247,129 
Inventory write-down             194,344       114,617       33,360 
Finance expenses                  34,371           689          583 
Loss (gain) from exchange 
 differences on cash and 
 equivalents                     (12,238)       31,579           -- 
Changes in operating assets 
and liabilities: 
Trade receivables, net           (70,930)      (92,188)    (161,689) 
Other current assets             138,909       229,641     (472,020) 
Prepaid expenses                  21,180       (33,333) 
Inventories                       (4,631)     (244,343)       6,995 
Operating lease right-of-use 
 asset                           179,323       135,266       48,766 
Trade payables                   (67,756)      127,565        9,422 
Operating lease liabilities     (181,624)     (134,681)     (45,911) 
Other current liabilities         32,617       243,134      (83,785) 
                              ----------   -----------   ---------- 
 
Net cash used in operating 
 activities                   (5,804,052)   (4,889,222)  (2,938,300) 
                              ----------   -----------   ---------- 
 
CASH FLOWS FROM INVESTING 
ACTIVITIES: 
Change in restricted deposit     (12,720)      (68,001) 
Purchase of property and 
 equipment                       (27,804)      (80,738)     (25,757) 
   Investment in short term 
    deposits                  (2,000,000) 
Net cash used in investing 
 activities                   (2,040,524)     (148,739)     (25,757) 
                              ----------   -----------   ---------- 
 
CASH FLOWS FROM FINANCING 
ACTIVITIES: 
Proceeds from exercise of 
 series A warrants (Note 
 10b)                          1,258,793     1,820,001 
Issuance of ordinary shares 
 in initial public offering, 
 net of issuance costs (Note 
 10c)                                 --            --    6,695,957 
Issuance of ordinary shares, 
 pre-funded warrants and 
 warrants in private 
 placement, net of issuance 
 costs (Note 10f and 10g)      4,553,992            --    4,106,699 
Receipt of loan from related 
 party                                --            --      245,000 
Repayment of loan from 
 related party                        --            --     (745,000) 
                              ----------   -----------   ---------- 
 
Net cash provided by 
 financing activities          5,812,785     1,820,001   10,302,656 
                              ----------   -----------   -- 

(MORE TO FOLLOW) Dow Jones Newswires

March 26, 2026 08:28 ET (12:28 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10